Publisher's Synopsis
Guide to Using Aldara
Aldara, or Imiquimod, is a topical cream with immunomodulatory properties, widely prescribed for treating actinic keratosis, superficial basal cell carcinoma, and external genital and perianal warts. It works by stimulating the immune system to release cytokines, proteins that help combat viruses and abnormal cells.
Applied directly to the affected area, Aldara is favored for its effectiveness and ease of use, making it a popular choice among healthcare providers. Initially approved by the FDA in 1997, Aldara was developed by 3M Pharmaceuticals and later marketed by Graceway Pharmaceuticals. The discovery of its immunomodulatory effects marked a significant breakthrough, offering a less invasive treatment for certain skin conditions.
Extensive clinical trials and studies have established Aldara's efficacy and versatility, securing its place in dermatological therapeutics. Its journey from discovery to widespread clinical use underscores the advancements in medical research and pharmacology.
